Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase

Archives of Virology

Volumn 156, Issue 5, 2011, Pages 793-801

  Dou, Jie ^a   Chen, Lili ^a   Xu, Ge ^a   Zhang, Lei ^a   Zhou, Huimin ^a   Wang, Hui ^a   Su, Zhenzhen ^a   Ke, Mengyun ^a   Guo, Qinglong ^a   Zhou, Changlin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BAICALEIN; BAICALIN; FLAVANONE DERIVATIVE; FLAVONOID; HEMAGGLUTININ; SIALIDASE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IC 50; LUNG; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOUSE; ORAL DRUG ADMINISTRATION; SENDAI VIRUS; SERUM; VIROLOGY; VIRUS CULTURE; VIRUS LOAD;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; FEMALE; FLAVANONES; FLAVONOIDS; HEMAGGLUTININS; INHIBITORY CONCENTRATION 50; LUNG; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; SENDAI VIRUS; SERUM; VIRAL LOAD; VIRAL PLAQUE ASSAY;

HUMAN PARAINFLUENZA VIRUS 1; MUS; PARAINFLUENZA VIRUS; PARAMYXOVIRIDAE; SCUTELLARIA BAICALENSIS; SENDAI VIRUS;

EID: 79955165306     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-0917-z     Document Type: Article

References (40)

1. Lamb RA, Parks GD (2006) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, pp 1449-1496.
2. Henrickson KJ, Kuhn SM, Savatski LL (1994) Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis 18: 770-779.
3. Chanock RM, Murphy BR, Collins PL (2001) Parainfluenza viruses. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott/The Williams & Wilkins Co, Philadelphia, pp 1341-1379.
4. Markwell MAK (1991) New frontiers opened by the exploration of host cell receptors. In: Kingsbury DW (ed) The paramyxoviruses. Plenum Press Inc, New York, pp 407-425.
5. Lamb RA, Kolakofsky D (1996) The paramyxoviruses. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp 577-604.
6. Evers DL, Chao CF, Wang X, Zhang ZG, Huong SM, Huang ES (2005) Human cytomegalovirus - inhibitory flavonoids: Studies on antiviral activity and mechanism of action. Antivir Res 68: 124-134.
7. Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y et al (2000) Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 52: 1563-1568.
8. Lai MY, Hsiu SL, Tsai SY, Hou YC, Chao PDL (2003) Comparison of metabolic pharmacokineties of baicalin and baicalein in rats. J Pharm Pharmacol 55: 205-209.
9. Xing J, Chen XY, Sun YM, Luan Y, Zhong DF (2005) Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharm Pharmacol 57: 743-750.
10. Liu TM, Jiang XH (2006) Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharmacol Sci 95: 1326-1333.
11. Xu G, Dou J, Zhang L, Guo QL, Zhou CL (2010) Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol Pharm Bull 33: 238-243.
12. Schepetiuk SK, Kok T (1993) The use of MDCK, MEK and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens. J Virol Methods 42: 241-250.
13. Boltz DA, Ilyushina NA, Arnold CS, Babu YS, Webster RG, Govorkova EA (2008) Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice. Antivir Res 80: 150-157.
14. Iwama H, Amagaya S, Ogihara Y (1987) Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopoly saccharide: a new pharmacological testing method. J Ethnopharmacol 21: 45-53.
15. Tsurita M, Kurokawa M, Imakita M, Fukuda Y, Watanabe Y, Shiraki K (2001) Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharmacol Exp Ther 298: 362-368.
16. Venables WN, Ripley BD (1997) Modern Applied Statistics. Springer, New York, pp 223-242, 297-321, 345-350.
17. Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-220.
18. Nishioka Y, Kyotani X, Miyamura M (1992) Influence of time of administration of a shosaiko-to extract granule on blood concentration of its active constituents. Chem Pharm Bull 40: 1335-1337.
19. Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH (2005) In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol 26: 241-246.
20. Wu JA, Attele AS, Zhang L, Yuan CS (2001) Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 29: 69-81.
21. Shen YC, Chiou WF, Chou YC, Chen CF (2003) Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465: 171-181.
22. Ciesielska E, Wolszczak M, Gulanowski B, Szulawska A, Kochman A, Metodiewa D (2004) In vitro antileukemic, antioxidant and prooxidant activities of Antoksyd S (C/E/XXI): a comparison with baicalin and baicalein. In Vivo 18: 497-503.
23. Woo AYH, Cheng CHK, Waye MMY (2005) Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism. Cardiovasc Res 65: 244-253.
24. Ma Z, Otsuyama K, Liu SQ, Abroun S, Ishikawa H, Tsuyama N et al (2005) Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 105: 3312-3318.
25. Ciesielska E, Gwardys A, Metodiewa D (2002) Anticancer, antiradical and antioxidative actions of novel Antoksyd S and its major components, baicalin and baicalein. Anticancer Res 22: 2885-2891.
26. Evers DL, Chao C, Wang X, Zhang Z, Huong S, Huang E (2005) Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antivir Res 68: 124-134.
27. Collins PL, Mottet G (1991) Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity. J Virol 65: 2362-2371.
28. Henrickson KJ (1991) Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates. J Infect Dis 164: 1128-1134.
29. Iorio RM, Bratt MA (1984) Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutininneuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. J Virol 51: 445-451.
30. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC et al (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353: 2667-2672.
31. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH et al (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108.
32. Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y et al (2007) Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. J Infect Dis 196: 249-257.
33. Hata M, Tsuzuki M, Goto Y, Kumagai N, Harada M, Hashimoto M et al (2007) High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR. Jpn J Infect Dis 60: 202-204.
34. Ilyushina NA, Bovin NV, Webster RG, Govorkova EA (2006) Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antivir Res 70: 121-131.
35. Govorkova EA, Fang HB, Tan M, Webster RG (2004) Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic antiinfluenza virus effects in MDCK cells. Antimicrob Agents Chemother 48: 4855-4863.
36. Smee DF, Bailey KW, Morrison AC, Sidwell RW (2002) Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin. Chemotherapy 48: 88-93.
37. Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD (2009) Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice. Antimicrob Agents Chemother 53: 2120-2128.
38. Ilyushina NA, Hay A, Yilmaz N, Boon ACM, Webster RG, Govorkova EA (2008) Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 52: 3889-3897.
39. Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA (2007) Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antiviral Ther 12: 363-370.
40. Eriksson B, Helgstrand E, Johansson NG, Larsson A, Misiorny A, Nore′n JO et al (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother 11: 946-951.